WEE1 and chronic myelogenous leukemia, BCR-ABL1 positive: Imatinib is a small molecule protein kinase inhibitor, which has the effect of blocking one or more tyrosine kinases, and it is mainly used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal sarcomas [2].